Can we skip opioids after bone surgery? new study tests a safer pain plan
NCT ID NCT07265557
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This pilot study compares two discharge pain plans for adults after major orthopedic surgery: one with opioids and one without. Researchers want to see if it's possible to run a larger trial that could reduce opioid use. About 100 patients will be randomly assigned to either plan, and the study tracks how well they follow the plan and their pain levels.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- discharge pain medication prescription (opioid-free vs. usual care with opioids)
- What this could lead to
- If successful, this could show that an opioid-free pain plan is feasible and effective, potentially reducing opioid dependence after orthopedic surgery.
- What could go wrong
- This is a small pilot study (100 people) focused on feasibility, not on proving pain control or safety. Results may not apply to all patients or surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mass
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?